A fully-automated bioreactor to culture human-induced pluripotent stem cells (hiPSCs) long-term has been developed by researchers at the Fraunhofer Translational Center for Regenerative Therapies.

A KAUST team of marine scientists and bioscientists has developed a cell-culturing technique that could lead to more accurate, interpretable and reproducible ...

Liquid nitrogen is used to cool the cell models grown in the bioreactor from about plus 23°C down to -196° within two seconds. The Fraunhofer researchers have also developed a special cell culture ...

Macrophages are crucial in immune responses, tissue repair and homeostasis, making them prime candidates for translational applications. Induced pluripotent stem cell (iPS cell)-derived macrophages ...

Human induced pluripotent stem cells (hiPSCs) are a powerful tool for innovative approaches, such as drug discovery, in vitro disease modelling, or regenerative therapies. However, such procedures ...

BETHLEHEM, Pa.--(BUSINESS WIRE)--ABEC, a global leader in engineered solutions and services for biotech manufacturing, has introduced its Advanced Therapy Bioreactor (ATB™) – a revolutionary platform ...

Production of recombinant monoclonal antibodies (mAbs) for therapeutic use is a multibillion dollar industry. At present, mammalian cell lines are the workhorses of the biotechnology industry, due to ...

FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) and HORIBA, Ltd. (President: Masayuki Adachi) ...

One of the most important advances in the field of cell biology came in the early 20th century, with the discovery that plant and animal cells could survive - and even replicate - outside the living ...